SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007340
Filing Date
2024-05-08
Accepted
2024-05-08 16:10:44
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20240331x10q.htm   iXBRL 10-Q 2411621
2 EX-31.1 pahc-20240331xex31d1.htm EX-31.1 8156
3 EX-31.2 pahc-20240331xex31d2.htm EX-31.2 8126
4 EX-32.1 pahc-20240331xex32d1.htm EX-32.1 3879
5 EX-32.2 pahc-20240331xex32d2.htm EX-32.2 4149
  Complete submission text file 0001558370-24-007340.txt   9213991

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20240331.xsd EX-101.SCH 52385
7 EX-101.CAL pahc-20240331_cal.xml EX-101.CAL 78477
8 EX-101.DEF pahc-20240331_def.xml EX-101.DEF 268607
9 EX-101.LAB pahc-20240331_lab.xml EX-101.LAB 402460
10 EX-101.PRE pahc-20240331_pre.xml EX-101.PRE 427605
91 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20240331x10q_htm.xml XML 1751366
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 24926118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)